Matches in SemOpenAlex for { <https://semopenalex.org/work/W3093641368> ?p ?o ?g. }
- W3093641368 abstract "Salivary gland carcinomas (SGC) account for less than 5% of head and neck malignant neoplasms, further subcategorized in over 20 histological subtypes. For the most part, treatment for advanced disease is guided by morphology. SGC in general respond poorly to standard chemotherapy, with short durability and significant toxicity. More recently, next-generation sequencing provided significant input on the molecular characterization of each SGC subtype, not only improving diagnostic differentiation between morphologically similar tumor types, but also identifying novel driver pathways that determine tumor biology and may be amenable to targeted therapy. Amongst the most common histological subtype is adenoid cystic carcinoma, which often harbors a chromosome translocation resulting in a MYB-NFIB oncogene, with various degrees of Myb expression. In a smaller subset, NOTCH1 mutations occur, conferring a more aggressive disease and potential sensitivity to Notch inhibitors. Salivary duct carcinomas may overexpress Her-2 and androgen receptor, with promising clinical outcomes after exposure to targeted therapies approved for other indications. Secretory carcinoma, previously known as mammary analogue secretory carcinoma, is distinguished by an ETV6-NTRK3 fusion that can both help differentiate it from its morphologically similar acinar cell carcinoma and also make it susceptible to Trk inhibitors. In the present article, we discuss the molecular abnormalities, their impact on tumor biology, and therapeutic opportunities for the most common SGC subtypes and review published and ongoing clinical trials and future perspectives for this rare diseases." @default.
- W3093641368 created "2020-10-29" @default.
- W3093641368 creator A5007020035 @default.
- W3093641368 creator A5049969201 @default.
- W3093641368 creator A5055616055 @default.
- W3093641368 creator A5062714009 @default.
- W3093641368 creator A5064335194 @default.
- W3093641368 date "2020-10-22" @default.
- W3093641368 modified "2023-10-15" @default.
- W3093641368 title "Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease" @default.
- W3093641368 cites W1495629113 @default.
- W3093641368 cites W1714636357 @default.
- W3093641368 cites W1938859726 @default.
- W3093641368 cites W1968996812 @default.
- W3093641368 cites W1983130111 @default.
- W3093641368 cites W1992118957 @default.
- W3093641368 cites W1998432526 @default.
- W3093641368 cites W2000150716 @default.
- W3093641368 cites W2005621869 @default.
- W3093641368 cites W2018406388 @default.
- W3093641368 cites W2019615138 @default.
- W3093641368 cites W2021982612 @default.
- W3093641368 cites W2027658726 @default.
- W3093641368 cites W2031579870 @default.
- W3093641368 cites W2032535154 @default.
- W3093641368 cites W2032738666 @default.
- W3093641368 cites W2034758824 @default.
- W3093641368 cites W2045791384 @default.
- W3093641368 cites W2082353122 @default.
- W3093641368 cites W2085714112 @default.
- W3093641368 cites W2098523473 @default.
- W3093641368 cites W2098641060 @default.
- W3093641368 cites W2107479915 @default.
- W3093641368 cites W2109916736 @default.
- W3093641368 cites W2124596967 @default.
- W3093641368 cites W2126191879 @default.
- W3093641368 cites W2141471081 @default.
- W3093641368 cites W2143684157 @default.
- W3093641368 cites W2144909477 @default.
- W3093641368 cites W2145665617 @default.
- W3093641368 cites W2153600956 @default.
- W3093641368 cites W2155961584 @default.
- W3093641368 cites W2160500782 @default.
- W3093641368 cites W2178274441 @default.
- W3093641368 cites W2239997257 @default.
- W3093641368 cites W2264048266 @default.
- W3093641368 cites W2291746651 @default.
- W3093641368 cites W2292871324 @default.
- W3093641368 cites W2342227699 @default.
- W3093641368 cites W2343095226 @default.
- W3093641368 cites W2462007408 @default.
- W3093641368 cites W2462865110 @default.
- W3093641368 cites W2509315795 @default.
- W3093641368 cites W2514847952 @default.
- W3093641368 cites W2548897214 @default.
- W3093641368 cites W2553335953 @default.
- W3093641368 cites W2574609272 @default.
- W3093641368 cites W2577862693 @default.
- W3093641368 cites W2587919588 @default.
- W3093641368 cites W2591753393 @default.
- W3093641368 cites W2601984321 @default.
- W3093641368 cites W2604409593 @default.
- W3093641368 cites W2605068311 @default.
- W3093641368 cites W2620374753 @default.
- W3093641368 cites W2747997276 @default.
- W3093641368 cites W2764015212 @default.
- W3093641368 cites W2766052404 @default.
- W3093641368 cites W2775239209 @default.
- W3093641368 cites W2783112448 @default.
- W3093641368 cites W2790254562 @default.
- W3093641368 cites W2791073967 @default.
- W3093641368 cites W2792603138 @default.
- W3093641368 cites W2794799875 @default.
- W3093641368 cites W2799931007 @default.
- W3093641368 cites W2800138464 @default.
- W3093641368 cites W2800562874 @default.
- W3093641368 cites W2889703062 @default.
- W3093641368 cites W2890007148 @default.
- W3093641368 cites W2890028769 @default.
- W3093641368 cites W2890046006 @default.
- W3093641368 cites W2891995288 @default.
- W3093641368 cites W2892052928 @default.
- W3093641368 cites W2892781089 @default.
- W3093641368 cites W2893307128 @default.
- W3093641368 cites W2901312960 @default.
- W3093641368 cites W2907262475 @default.
- W3093641368 cites W2913416111 @default.
- W3093641368 cites W2915233887 @default.
- W3093641368 cites W2921497169 @default.
- W3093641368 cites W2922325434 @default.
- W3093641368 cites W2922525174 @default.
- W3093641368 cites W2947220160 @default.
- W3093641368 cites W2947440683 @default.
- W3093641368 cites W2947505630 @default.
- W3093641368 cites W2947983979 @default.
- W3093641368 cites W2949006125 @default.
- W3093641368 cites W2965862978 @default.
- W3093641368 cites W2967486103 @default.
- W3093641368 cites W2971230454 @default.
- W3093641368 cites W2971684115 @default.